🟢 Cue Biopharma is trading 12.34% up today — catalyst unconfirmed

Cue Biopharma is trading 12.34% up at $29.32 after no clear company-specific announcement was identified for August 11, 2026.

• Investor-relations page lists its latest release as the August 3, 2026 CFO appointment and CUE-221 investigational new drug submission announcement; no August 11 release is shown.
• The broader market is weaker, so macro sentiment does not clearly explain the move.
• The catalyst remains unconfirmed.